MDCG Surgical Mesh Implants Guidance

The Medical Device Coordination Group (MDCG) has published a new guidance document on Vigilance System for Urogynaecological Surgical Mesh Implants. This guidance provides detailed clarification on vigilance reporting for Urogynaecological Surgical Mesh Implants used in the treatment of Pelvic Organ Prolapse and Stress Urinary Incontinence. It provides comprehensive guidance for reporting serious incidents, periodic summaries, and trend analyses, including IMDRF codes to be used in these reports. 

How does this guidance benefit manufacturers? 

The document is a crucial resource for manufacturers, healthcare professionals, and regulatory bodies, aiming to enhance patient safety and improve the monitoring and reporting processes for these medical devices. By following the MDCG’s recommendations, stakeholders can ensure better tracking of device performance and more effective management of potential risks.